FindMyRecallSubscribe
Class I: serious health riskTerminated

Lupin Limited (Unit 1) Mibelas 24 Fe Recall

Mibelas 24 Fe (Norethindrone acetate and Ethinyl estradiol 1 mg/0

Lupin Limited (Unit 1) · Pithampur, N/A

Risk level
Class I
Reported by FDA
Aug 23, 2017
Recall ID
D-1093-2017
Check your lot numberHow we source this data

Summary

Lupin Limited (Unit 1) recalled Mibelas 24 Fe starting May 16, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-1093-2017 on Aug 23, 2017. Reason: Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package. Status: Terminated.

Why it was recalled

Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.

Product description

Mibelas 24 Fe (Norethindrone acetate and Ethinyl estradiol 1 mg/0.02 mg chewable and ferrous Fumarate 75 mg) Tablets, wallet of 28 tablets (NDC 68180-911-11), Carton of 3 wallets (NDC 68180-911-13), Rx Only, Manufactured by: Lupin Limited, India, Distributed by Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202

Lot numbers, UPCs & expiration codes

Batch Number L600518; Exp. 05/18

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1093-2017
Classification
Class I
Status
Terminated
Recall initiated
May 16, 2017
FDA report date
Aug 23, 2017
Quantity
24,652 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Limited (Unit 1)

Original FDA data

Every field from FDA enforcement report D-1093-2017, exactly as published.

Show all FDA fields
City
Pithampur
Status
Terminated
Country
India
Event ID
77323
Address
Unit 1, Plot 2, SEZ, Phase II,
Address (line 2)
Misc Zone Apparel Park, Dist. Dhar
Code information
Batch Number L600518; Exp. 05/18
Report date
Aug 23, 2017
Product type
Drugs
Recall number
D-1093-2017
Classification
Class I
Recalling firm
Lupin Limited (Unit 1)
Product quantity
24,652 tablets
Termination date
May 30, 2019
Reason for recall
Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mibelas 24 Fe (Norethindrone acetate and Ethinyl estradiol 1 mg/0.02 mg chewable and ferrous Fumarate 75 mg) Tablets, wallet of 28 tablets (NDC 68180-911-11), Carton of 3 wallets (NDC 68180-911-13), Rx Only, Manufactured by: Lupin Limited, India, Distributed by Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202
Distribution pattern
Nationwide
Recall initiation date
May 16, 2017
Initial firm notification
Letter
Center classification date
Aug 15, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1093-2017, published Aug 23, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls